Press Releases June 3, 2026 10:31 PM

3D Systems Announces Pricing of $50 Million Upsized Public Offering

3D Systems Prices $50 Million Upsized Public Offering of Common Stock

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
DDD

3D Systems Corporation announced the pricing of an upsized underwritten public offering of approximately 16.4 million shares at $3.05 per share, raising about $50 million in gross proceeds. The offering is expected to close on June 5, 2026, with an option for underwriters to purchase additional shares. The funds will support the company's initiatives in 3D printing technologies across multiple high-value markets.

3D Systems Announces Pricing of $50 Million Upsized Public Offering
DDD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • 3D Systems is raising $50 million through a public offering at $3.05 per share.
  • The offering is upsized and expected to close on June 5, 2026, with an option for underwriters to buy more shares.
  • 3D Systems serves industries including medical, aerospace, defense, transportation, AI infrastructure, and durable goods with its 3D printing solutions.

ROCK HILL, S.C., June 03, 2026 (GLOBE NEWSWIRE) -- Today, 3D Systems Corporation (NYSE: DDD) (“3D Systems”) announced the pricing of its previously announced upsized underwritten public offering of 16,393,443 shares of common stock at a public offering price of $3.05 per share for total gross proceeds of approximately $50 million. All of the shares of common stock are being offered by 3D Systems. The offering is expected to close on June 5, 2026, subject to customary closing conditions. In addition, 3D Systems has granted the underwriters a 30-day option to purchase up to an additional 2,459,016 shares of common stock at the public offering price, less underwriting discounts and commissions.

Needham & Company and Craig-Hallum are acting as joint book-running managers for the offering.

A registration statement relating to these securities was filed with the U.S. Securities and Exchange Commission (the ”SEC”) and declared effective on May 27, 2026. Copies of the registration statement can be accessed through the SEC’s website free of charge at www.sec.gov. A preliminary prospectus supplement and an accompanying prospectus relating to and describing the terms of the offering were filed with the SEC and are available free of charge by visiting EDGAR on the SEC’s website at www.sec.gov. When available, copies of the final prospectus supplement and the accompanying prospectus related to the offering can be accessed through the SEC’s website free of charge at www.sec.gov or obtained free of charge from either of the joint book-running managers for the offering: Needham & Company, LLC, 250 Park Avenue, 10th Floor, New York, NY 10177, Attn: Prospectus Department, prospectus@needhamco.com or by telephone at (800) 903-3268; or Craig-Hallum Capital Group LLC, Attention: Equity Capital Markets, 323 N Washington Ave., Suite 300, Minneapolis, MN 55401, by telephone at (612) 334-6300 or by email at prospectus@chlm.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

About 3D Systems

Nearly 40 years ago, Chuck Hull’s curiosity and desire to improve the way products were designed and manufactured gave birth to 3D printing, 3D Systems, and the additive manufacturing industry. Since then, that same spark continues to ignite the 3D Systems team as we work side-by-side with our customers to change the way industries innovate. As a full-service solutions partner, we deliver industry-leading 3D printing technologies, materials and software to high-value markets such as medical and dental; aerospace, space and defense; transportation and motorsports; AI infrastructure; and durable goods. Each application-specific solution is powered by the expertise and passion of our employees who endeavor to achieve our shared goal of Transforming Manufacturing for a Better Future.

Forward-Looking Statements

Certain statements made in this release that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding 3D Systems’ expectations regarding the completion of the offering. Forward-looking statements involve known and unknown risks and uncertainties and no assurance can be given that the offering will be consummated on the terms described or at all. Completion of the offering and the terms thereof are subject to numerous factors, many of which are beyond the control of 3D Systems, including market conditions, failure of customary closing conditions and the risk factors and other matters set forth in its periodic filings with the SEC. The forward-looking statements included in this press release are made only as of the date of the statement. 3D Systems undertakes no obligation to update or review any forward-looking statements made by management or on its behalf, whether as a result of future developments, subsequent events or circumstances or otherwise.

Investor Contact: investor.relations@3dsystems.com

Media Contact: press@3dsystems.com


Risks

  • Completion of the offering is subject to customary closing conditions and market factors, which may delay or prevent the closing.
  • Market conditions may adversely affect the final terms or success of the offering.
  • Forward-looking statements carry typical risks including uncertainty about whether the company will use the proceeds effectively to stimulate growth.

More from Press Releases

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems Jun 6, 2026 All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration Jun 6, 2026 Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress Jun 6, 2026 InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering Jun 5, 2026 Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 5, 2026